Literature DB >> 27931879

The role of immunonutritional support in cancer treatment: Current evidence.

Isabel Prieto1, Sara Montemuiño2, Javier Luna3, Maria Victoria de Torres4, Enrique Amaya5.   

Abstract

The significant role of the immune system in cancer treatment has given rise to an emerging field of study within oncology, and one that is attracting increasing attention from researchers. Immunotherapy has demonstrated that the immune system is crucial in the fight against cancer. This challenge has led researchers to analyze whether the immune influencing capacity of immunonutrition may aid in improving immune status, modulate the acquired immune response, decrease the treatment toxicity and improve patient outcomes. Immunonutrition, new developed formulas has been demonstrated to improve outcome in surgical patients. This improvement is related to the modulation of the inflammatory response in the peri-operative period. The aim of this review is to analyze current evidence on the benefit of immunonutrition in patients undergoing pro-inflammatory processes in cancer, such as receiving chemotherapy or radiation treatment. With this aim, authors have analyzed the problem studying different aspects: the role of the immune system in cancer treatment, current evidence regarding immunonutrition in perioperative period, current evidence regarding immunonutrition in cancer patients and the relation between immunity and radiotherapy. The conclusions of this review confirm that immunonutrition formulas could modulate inflammatory and immune response in cancer patients. This effect decreases acute toxicity, although the pathways and the measure of this immune response are unclear. Immunonutrition is an emerging field in oncology, and further research is needed.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Cancer nutrition; Immunonutrition; Immunotherapy

Mesh:

Year:  2016        PMID: 27931879     DOI: 10.1016/j.clnu.2016.11.015

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  12 in total

Review 1.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 2.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

3.  Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.

Authors:  Yaqing Dai; Xiaobin Fu; Tingting Li; Qiwei Yao; Liyu Su; Huiyan Su; Jiancheng Li
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  Potential Impact of Nutrition on Immune System Recovery from Heavy Exertion: A Metabolomics Perspective.

Authors:  David C Nieman; Susan Hazels Mitmesser
Journal:  Nutrients       Date:  2017-05-18       Impact factor: 5.717

5.  Clinical significance of prognostic nutritional index in patients with glioblastomas.

Authors:  Jin-Duo Ding; Kun Yao; Peng-Fei Wang; Chang-Xiang Yan
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities.

Authors:  Naoko Miura; Fumihiro Shoji; Yuka Kozuma; Gouji Toyokawa; Koji Yamazaki; Sadanori Takeo
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-01-29       Impact factor: 1.520

7.  Immunonutrition Changes Inflammatory Response in Colorectal Cancer: Results from a Pilot Randomized Clinical Trial.

Authors:  Mateusz Wierdak; Marcin Surmiak; Katarzyna Milian-Ciesielska; Mateusz Rubinkiewicz; Anna Rzepa; Michał Wysocki; Piotr Major; Stanisław Kłęk; Michał Pędziwiatr
Journal:  Cancers (Basel)       Date:  2021-03-22       Impact factor: 6.639

8.  Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy.

Authors:  Ryoji Yoshida; Shunsuke Gohara; Junki Sakata; Yuichiro Matsuoka; Akiyuki Hirosue; Kenta Kawahara; Sho Kawaguchi; Yuka Nagao; Keisuke Yamana; Masashi Nagata; Daiki Fukuma; Ryo Toya; Ryuji Murakami; Akimitsu Hiraki; Masanori Shinohara; Hideki Nakayama
Journal:  Transl Oncol       Date:  2020-08-24       Impact factor: 4.243

Review 9.  Exploring the food-gut axis in immunotherapy response of cancer patients.

Authors:  Edda Russo; Giulia Nannini; Monica Dinu; Giuditta Pagliai; Francesco Sofi; Amedeo Amedei
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

10.  Serum albumin levels and serum albumin-globulin ratio are associated with poor prognosis in glioblastoma.

Authors:  Kugeluke Yalikun; Tuerhong Tuersun; Maiaitituersun Abudula; Maijudan Tiheiran; Qiang Fu; Dilimulati Yisireyili; Qingjiu Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.